This article is more than 5 years old. Information may no longer be current.
The 5 most-viewed articles by Cardiology Today’s Intervention readers in August
Click Here to Manage Email Alerts
Cardiology Today’s Intervention has compiled a list of the top five stories posted to Healio.com/Intervention
in the month of August.
This month, Cardiology Today’s Intervention readers were most interested in the outcomes of beta-blockers in patients with heart failure and MI, genomics of antiplatelet therapy, benefits and harms of renal angioplasty with stent placement vs. medical therapy alone in adults with atherosclerotic renal artery stenosis, stent thrombosis rates in an early experience with a bioresorbable vascular scaffold, the efficacy of covered stents vs. bare-metal stents in aortoiliac arterial disease, and much more.
Beta-blockers fail to improve outcomes, may raise HF risk after PCI
Despite increasing use, beta-blockers did not improve mortality rates or reduce CV events for patients aged at least 65 years with stable angina but no history of MI or HF, according to a new study. Read More
Study of genomics of antiplatelet therapy continues
The TAILOR-PCI study has received an additional $7 million from the National Heart, Lung and Blood Institute to complete research on whether prescribing antiplatelet therapy based on a patient’s CYP2C19 genotype will prevent MI, stroke, unstable angina and CV death in patients who undergo PCI. Read More
No evidence angioplasty superior to medical therapy in renal artery stenosis
Among patients with atherosclerotic renal artery stenosis, the strength of evidence for the relative benefits and harms of percutaneous transluminal renal angioplasty with stent placement vs. medical therapy alone is low, according to an analysis published in the Annals of Internal Medicine. Read More
BVS yield acceptable TLF rates, higher stent thrombosis at midterm follow-up in GHOST-EU registry
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds in an all-comers population was associated with “acceptable” rates of target lesion failure at midterm follow-up, but an increased rate of stent thrombosis compared with contemporary metallic stents, researchers reported in Catheterization and Cardiovascular Interventions. Read More
Covered stents deliver lasting patency benefit vs. BMS in aortoiliac artery disease
In patients with aortoiliac artery disease, covered stents conferred a patency advantage compared with bare-metal stents out to 5 years, according to data from the COBEST trial. Read More